The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Min Z, Elrufay R, Cho CY, Elapavaluru S, Bhanot N

Ceftaroline-related acute eosinophilic pneumonia.

Lung India : official organ of Indian Chest Society 2021 Jul-Aug;38;368-373 — 2021 Jul-Aug — 368-373

Griffiths CL, Gutierrez KC, Pitt RD, Lovell RD

Eosinophilic pneumonia induced by ceftaroline.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2014 Mar 01;71;403-6 — 2014 Mar 01 — 403-6

Desai KR, Burdette SD, Polenakovik HM, Hagaman J, Pleiman CM

Ceftaroline-induced eosinophilic pneumonia.

Pharmacotherapy 2013 Jul;33;e166-9 — 2013 Jul — e166-9